Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545623 · ClinicalTrials.gov registry record · Phase 2
Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
A Phase 2 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 2
- Development phase
- 130
- Enrollment target
NCT00545623 is a Phase 2 study that has completed, run by Boston University. The registered enrollment target is 130 participants.
The verdict
NCT00545623, a Phase 2 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 130 participants
- Enrollment target
Study Summary
The aims of the study are to investigate individual, combined and added effects of acupuncture and the relaxation response in reducing gastrointestinal symptoms, improving medication adherence and quality of life among people living with HIV/AIDS. The study will also explore the mechanism of these therapeutic effects of acupuncture and the relaxation response.
Interventions
- PROCEDURE Acupuncture
- BEHAVIORAL Relaxation Response
- OTHER sham acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545623
The ClinicalTrials.gov registry entry for NCT00545623 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acupuncture is the first listed.
NCT00545623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545623 about?
NCT00545623 is a clinical study titled "Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence". The aims of the study are to investigate individual, combined and added effects of acupuncture and the relaxation response in reducing gastrointestinal symptoms, improving medication adherence and quality of life among people living with HIV/AIDS. The study will also explore the mechanism of these t...
What is the current status of trial NCT00545623?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 130 participants. The study started on 2007-04. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00545623?
The interventions under investigation include: Acupuncture (PROCEDURE), Relaxation Response (BEHAVIORAL), sham acupuncture (OTHER).
Who is sponsoring clinical trial NCT00545623?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.